Searched for
SERUM INSTITUTE S COVOVAX
Covid jab Covovax as heterologous booster to be available on CoWIN soon; to cost Rs 225 per doseThe move comes after a letter was written by Prakash Kumar Singh, Director, Serum Institute of India (SII) to the Union health ministry on ...- Serum Institute seeks inclusion of Covovax on CoWIN as heterologous booster dose for adultsLast month, COVID-19 Working Group headed by Dr N K Arora had also recommended to the health ministry inclusion of Covovax on the CoWIN por...
- SII seeks inclusion of Covid jab Covovax in CoWIN portal as heterologous booster dose for adultsThe Drug Controller General of India (DCGI) on January 16 approved market authorisation for Covovax as a heterologous booster dose for adul...
- DGCI approves Covid-19 vaccine Covovax as heterologous booster dose"The Subject Expert Committee of the CDSCO on Wednesday deliberated on the issue and had recommended for market authorisation of Covid jab ...
- Govt panel recommends market authorisation for Covovax jab as heterologous booster dosePrakash Kumar Singh, director (government and regulatory affairs) at Serum Institute of India (SII) had recently written a letter to Drugs ...
- NTAGI panel recommends inclusion of Covovax in vaccination drive for 12-17 age group"The COVID-19 working group of the NTAGI (National Technical Advisory Group on Immunisation) had earlier reviewed data related to Covovax a...
- Govt panel recommends inclusion of Covovax in national Covid vaccination drive for those aged 12 and aboveThe COVID-19 Working Group has now recommended to the Standing Technical Sub-Committee of the National Technical Advisory Group on Immunisa...
- Serum Institute seeks Covovax's inclusion in Covid vaccination drive for 12 years and aboveIndia's drug regulator had granted restricted emergency use authorisation to Covovax for the 12 to 17 years age group subject to certain co...
- DCGI's EUA nod to SII's Covovax for 12-17 yrs age group; Poonawalla says younger age groups to follow shortlyIt is the fourth vaccine to receive the regulator's nod for use among those below 18 years.
- Covid: Govt panel recommends permission for phase-3 trial of Covovax as booster dose in adultsThe Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organisation had on Friday recommended giving permission for...
- Govt panel recommends EUA for Covid vaccine Covovax for 12-17 age groupThe Drugs Controller General of India (DCGI) had approved Covovax for restricted use in emergency situation in adults on December 28. It ha...
- A game-changing pill and two new vaccines will bolster India's fight against Covid variantsThe recommendations have been sent to the Drug Controller General of India (DCGI), which will soon decide on their approval, people in the ...
- CDSCO panel recommends emergency use authorisation for SII's Covid vaccine Covovax"The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) reviewed the emergency use autho...
- DCGI seeks more data from SII over its application seeking emergency authorisation for CovovaxSerum Institute of India (SII) had sent an application to the DCGI in October for the grant of market authorisation of Covovax for restrict...
- Govt panel seeks additional data from SII, says Covovax not yet been approved in country of originSII had put in an application to the DCGI in October for grant of market authorisation of Covovax for restricted use in emergency situation...
- Serum Institute seeks DCGI nod for Covid vaccine CovovaxBy Payal Banerjee New Delhi, The Serum Institute of India on Friday sought permission from the Drugs Controller General of India (DCGI) to ...
- Serum Institute may face delay in Covovax launchIndia’s drug regulator has asked for the immunogenicity data from Serum Institute as the vaccine is not yet appoved by the US FDA.
- Hopeful of launching Covovax for adults in October this year, for children in Q1-2022: Serum CEOHe also thanked the government for all the support provided to Serum Institute and said the company is always trying to expand its Covishie...
- Serum Institute manufacturing first batch of Covovax COVID-19 vaccine, says Adar PoonawallaIn March this year, Poonawalla had said that the clinical trials of Covovax vaccine have begun in India and the company hopes to launch it ...
- SII aims to launch Covovax by September as US eases suppliesThe Pune-based vaccine maker has received the first lot of supplies of key raw materials for Covovax production, company insiders told ET. ...
Load More
